Dr Jason Carroll, Principal Investigator at the CRUK Cambridge Institute has been awarded an ERC consolidator award for €2 million which will be used to understand how estrogen receptor (ER) can contribute to breast cancer cell growth.
Jason says, “specifically, we are interested in identifying how parallel hormonal pathways can influence ER activity and whether there are opportunities for exploiting existing hormonal therapies for controlling ER+ breast cancer”.
